Genmab A/S Files 6-K, Incorporates into S-8 Filings
Ticker: GNMSF · Form: 6-K · Filed: May 21, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, corporate-governance
TL;DR
Genmab filed a 6-K on 5/21/25, updating its Articles of Association and linking it to existing S-8 filings.
AI Summary
Genmab A/S filed a Form 6-K on May 21, 2025, to report updates. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File No. 333-284876. The report includes their Articles of Association as Exhibit 3.1.
Why It Matters
This filing serves to update the public record and ensure ongoing compliance with SEC regulations, particularly for companies with outstanding employee stock registration statements.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically impact stock price.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 333-232693 (document_id) — S-8 Registration Statement File Number
- 333-253519 (document_id) — S-8 Registration Statement File Number
- 333-262970 (document_id) — S-8 Registration Statement File Number
- 333-277273 (document_id) — S-8 Registration Statement File Number
- 333-284876 (document_id) — S-8 Registration Statement File Number
- May 21, 2025 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing by Genmab A/S?
The purpose of this Form 6-K filing is to report updates and to be incorporated by reference into Genmab A/S's existing registration statements on Form S-8.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on May 21, 2025.
Which specific registration statements will this filing be incorporated into?
This filing will be incorporated into Genmab A/S's registration statements on Form S-8 with File Numbers 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What document is included as an exhibit in this filing?
The Articles of Association of Genmab A/S are included as Exhibit 3.1 in this filing.
What is the principal executive office address for Genmab A/S?
The address of Genmab A/S's principal executive offices is Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 21, 2025 regarding GENMAB A/S (GNMSF).